Tuesday, May 30, 2017
Novomed Group, France's leader in the market of disposable medical kits, is happy to announce the acquisition of 100% of Mediq France's shares, bought from Dutch Company, Mediq.
Through this acquisition, the new group aspires to become a European leader in the medical materials market and aims to strengthen its digital offering as well as its positioning on the general and specialist practitioners segments.
Hervé Liebermann, Novomed Group CEO, said: "There's an obvious complementarity between our Companies that this strategic acquisition provides: complementarity between Novomed's production & sourcing expertise and Mediq's mastery of online distribution on the one hand, and complementarity between our clienteles (hospitals and independent practitioners) on the other. This marriage will help us to build a French medical materials champion capable of accelerating its digital transition and its international development."
Mediq France Management will continue to exist after the merging of the two companies into one Group.
Aurélie Descubes, Mediq France CEO, added, "Mediq France has succeeded in implementing major changes in its organization to address our customers' needs more efficiently. Our joining up with Novomed Group gives us the opportunity to move forward. With more than 100 000 clients in France and in Europe, the group will be unique in the innovation of its products and its service offering. With this in mind, our ability to continue our rapid growth in the digital field will be vital to achieve our strategic goals.
The operation was financed by senior and junior mezzanine debt arranged by Capzanine and through bank syndication including LCL, BNP Paribas and Caisse d'Epargne Ile-de-France, cofinanced by BPIfrance. The financial due-diligence was carried out by Aca Nexia, while PGA acted as legal advisors and D&A as financial advisors for Novomed Group's shareholders. Mediq Group was advised by Jones Day.
